By filling out the form, you'll receive access to trend analysis, educational videos, and other trading resources from INO.com. Institutions with over $100MM in AUM must disclose their option holdings (both put and call) in regulatory filings . $314 million of Total revenue in 2021, representing an increase of 309% over 2020. DNA.WS / Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share institutional put/call ratios is shown in the following chart. Industry: Biotechnology. To comply with law, a valid court order, a judicial proceeding, subpoenas, warrants, bankruptcy proceedings, or in connection with any legal process, provided that we will not disclose your Biological Information without a valid subpoena or search warrant specific to your Biological Information. In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company's shares of Class A common stock and public warrants are expected to trade on the New York Stock Exchange beginning on September 17, 2021 under the ticker symbols "DNA" and "DNA.WS," respectively. Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company's shares of Class A common stock and public warrants are expected to trade on the New York Stock Exchange beginning on September 17, 2021 under the ticker symbols "DNA" and "DNA.WS," respectively.Ginkgo Bioworks . Just curious on your thoughts to favor commons in . Special purpose acquisition company Soaring Eagle Acquisition (SRNG) and Ginkgo Bioworks on Friday reported the completion of the proposed merger between the companies. The shares of New SRNG Class A common stock and New SRNG warrants described above became shares of New Ginkgo Class A common stock or New Ginkgo warrants, as applicable, upon consummation of the . BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended . Website: https://www.ginkgobioworks.com. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks . In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company's shares of Class A common stock and public warrants are expected to . BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended . Nasdaq 100. Boston-based Ginkgo is exploring a potential combination with Soaring Eagle Acquisition, Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants. Free forex prices, toplists, indices and lots more. (e.g., puts, calls, warrants, options, convertible securities) 1. The MarketWatch News Department was not involved in the creation of this content. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. The company's technology platform is bringing biotechnology into consumer goods markets, enabling fragrance, cosmetic, nutrition, and food companies to make better products. An easy way to get Ginkgo Bioworks Holdings, Inc real-time prices. Ginkgo was founded in 2008 by Barry Canton, Austin Che, Jason Kelly, Tom Knight, and Reshma Shetty. BY GINKGO BIOWORKS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION. Tom, a computer science professor at MIT who had been part of the early days of the computer revolution, saw another revolution on the horizon: what could be possible if we could program cells as easily as we program computers? About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks, a company that designs organisms that can treat liver disorders or recreate the scent of an extinct Hawaiian hibiscus, is considering going public through a merger with a SPAC backed by Harry Sloan, Bloomberg reports, citing people with knowledge of the matter. According to the company, it "is building a platform to enable customers to program cells as easily as we can program computers." About Ginkgo Corporate Profile Headquartered in Boston, Ginkgo Bioworks is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks Holdings, Inc. About DNA. The company was incorporated in 2020 and is based in New York, New York. The company also reported revenues of $44 million from its biosecurity business for the first half of the year, relative to its original projection for full-year revenues of $50 million. N/A. SRNG Ginkgo Bioworks: Baillie Gifford tells Barrons it has reduced shares of Amazon and Tesla and Increased Gingko (PIPE) and Moderna as platfroms. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. CET Central Securities Corporation. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. Unchanged. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange under the ticker symbols "DNA" and "DNA.WS" respectively. DATA AS OF Feb 14, 2022. With such a steep P/S . Ginkgo Bioworks and the . "Old Ginkgo warrant" means each warrant to purchase shares of Old Ginkgo capital stock. The consensus estimate was a loss of $0.05 per share on revenue of $94.8 million. ET by Tomi Kilgore Barron's Ginkgo Bioworks Stock Sinks on Short Seller Report Trading under the ticker symbol DNA, the company, which raised $1.6 billion through the SPAC merger, is now looking to continue growing its cell programming platform "to solve even bigger problems with biology", from alt-materials to sustainable protein. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results. The business combination was approved at a special meeting of Soaring Eagle stockholders on . Shares opened at $11.15 apiece under ticker . Ginkgo Bioworks is in the process of merging with a SPAC called Soaring Eagle Acquisition Corp. (SRNG). If we are required to . The combined entity is called Ginkgo Bioworks Holdings. SRNG and Ginkgo merger details Ginkgo completed its business combination with SRNG on Sept. 16. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Sector - Industry - Employees - Founded 2020 Address 955 Fifth Avenue New York, NY, 10075 United States Phone Number. The Class A common stock and warrants of Ginkgo Bioworks Holdings, Inc. are expected to commence trading on the NYSE the day after the closing of the Business Combination under the symbols "DNA" and "DNA.WS," respectively. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange under the ticker symbols "DNA" and "DNA.WS" respectively. Major holders that have opened new positions in DNA.WS / Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share include Weiss Asset Management LP, Darlington Partners Capital Management, Lp, Privium Fund Management B.V., Privium Fund Management (UK) Ltd, Skaana Management L.P., Boothbay Fund . In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company's shares of Class A common stock and public warrants are expected to trade on the New York Stock Exchange beginning on September 17, 2021 under the ticker symbols "DNA" and "DNA.WS," respectively. Ginkgo Bioworks, Inc. . The Class A common stock and warrants of Ginkgo Bioworks Holdings, Inc. are expected to commence trading on the NYSE the day after the closing of the Business Combination under the symbols "DNA" and "DNA.WS," respectively. Bowlero Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50: $11.50: 1.00: $3.40: 55,119: $12.18: $1,304,067,558: BOWL: Bowlero Corp. Class A: Common stocks: Analyze: BOXD+: Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise . Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to advance treatments for orphan and rare diseases. View live DNA/W stock warrant chart, financials, and market news. The company also provided guidance above the consensus estimates. I am drawn to the appeal of holding warrants due to their lower price point and leverage, or ability to buy more for every $10 dollars. About Ginkgo Bioworks Holdings, Inc. 27 DRYDOCK AVENUE 8TH FLOOR, BOSTON, Massachusetts, 2210, United States +1 877 422-5362 Ginkgo Bioworks Holdings Inc is building a platform to enable customers. . Warrant. GINKGO BIOWORKS HOLDINGS, INC. (Exact name of registrant as specified in its charter) . Warrant (DNA.WS) Nasdaq Listed. The Company's Class A ordinary shares and warrants will continue to trade on Nasdaq until the transfer is complete. Trend Analysis will be sent directly to your inbox. . Add to Watchlist. Get Ginkgo Bioworks Holdings Equity Warrant Exp 1st Aug 2026 (DNA":NYSE) real-time stock quotes, news, price and financial information from CNBC. We enter into a written agreement with each Partner that requires the Partner to do the following: The company opted to go public by way of a SPAC, merging with . 2021 2020 2021 2020 Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders $ (101,881 ) $ (26,055 . Its common stock and warrants started trading on the NYSE under the new ticker symbols "DNA" and. The Company's Class A ordinary shares and warrants will continue to trade on Nasdaq until the transfer is complete. . Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts. View live DNA/W stock warrant chart, financials, and market news. The newly created entity's shares of Class A common stock and public warrants will start trading on Sept. 17 on the New . September 17, 2021. When you access a Ginkgo product or one of our Partner's products that includes a companion kit, we will share the needed information with the Partner so that the Partner can fulfill your order. 31 new Cell Programs added in 2021 . Ginkgo Bioworks Hldgs (DNA) reported a Quarter December 2021 loss of $0.01 per share on revenue of $148.5 million. DNA share was up 6%, while the warrant was down almost 12% today. In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company's shares of Class A common stock and public warrants are expected to trade on the New York Stock Exchange beginning on September 17, 2021 under the ticker symbols "DNA" and "DNA.WS," respectively. "Warrant Agreement" means the Warrant Agreement, dated as of February 23, . Soaring Eagle Acquisition Acquisition Corp (SRNG) has struck a $15B SPAC deal to take cell programming company Ginkgo Bioworks public. The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange under the ticker symbols "DNA" and "DNA.WS" respectively. Title of Derivative Security (Instr. Ginkgo's market debut is one of the largest in biotech history. Over $1.5 billion cash balance, providing meaningful multi-year runway as we drive towards profitability. $314 million of Total revenue in 2021, representing an increase of 309% over 2020. 3) 2. . VTI Vanguard Total Stock Market Index Fund ETF Shares. About Ginkgo Bioworks Headquartered in Boston , Ginkgo Bioworks uses the most advanced technology on the planet - biology - to grow products instead of manufacture them. An ape sees opportunity here for tomorrow trades. MONDAY. Equity DNA+ Ginkgo Bioworks Holdings Equity Warrant Exp 1st Aug 2026 *W EXP 02/23/2026. ** Based on 31,729,414 shares of Common Stock outstanding as of June 11, 2019, comprised of (i) 25,388,643 shares of Common Stock outstanding as of . Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. SRNGW warrants are surging, up over 24% pre-market to $2.45. new york, september 14, 2021--soaring eagle acquisition corp. (the "company" or "soaring eagle") (nasdaq: srngu, srng, srngw) announced today that its business combination (the "business. 31 new Cell Programs added in 2021, representing 72% growth over 2020. Ginkgo Bioworks Holdings annual and quarterly earnings per share history from 2021 to 2021. Ginkgo's total revenues for the period increased to $88 million from $31 million, and revenues from its foundry business rose to $44 million from $31 million. It's free, It's informative, It's on the money. Ginkgo Bioworks is a Boston-based biotech company. The company's platform is enabling biotechnology applications across. For fans of the biotech boom, today marks an important debut as Ginkgo Bioworks (NYSE: DNA) begins trading. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Is Ginkgo the AWS of synthetic biology? While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. Ginkgo Bioworks Reports Fourth Quarter and Full Year 2021 Financial Results. and Ginkgo Bioworks, Inc. ("Ginkgo"), among other things, each share of Soaring . EXFY Expensify Inc. AMD Advanced Micro Devices Inc. UA Under Armour Inc. PFIE Profire Energy Inc. TFSL TFS Financial Corp. CXXIF C21 Investments Inc. RDN Radian Group Inc. ADM Archer-Daniels-Midland Co. RSHN Rushnet Inc. Go. The company serves various end markets, including specialty chemicals . GINKGO BIOWORKS HOLDINGS (NYSE: DNA) is owned by 49.44% institutional shareholders, 13.95% GINKGO BIOWORKS HOLDINGS insiders, and 36.61% retail investors. Add to Portfolio. APR 04 07:58:22pm DNA+. At the Merger Effective Time, the Acquiror Delaware Charter shall be amended to change Acquiror's name to "Ginkgo Bioworks Holdings, Inc." (c) At the Domestication Effective Time, . Ginkgo has also actively supported a number of COVID . . 28/03/2022 08:00:10 1-888-992-3836 Free . DNA Stock Insider Trading NYSE:DNA Based on the 39 latest insides trades, we have calculated the insider power to be positive at a ratio of 10.135. Change in fair value of warrant liabilities includes the change in fair value of the Private Placement Warrants and the Public Warrants, which are classified as liabilities, and were assumed as part of the Business Combination. . The common stock and public warrants will begin trading today on the NYSE. The company's platform is market agnostic and enables biotechnology . Learn about the SCoRE Business combination of Ginkgo Bioworks and Soaring Eagle Acquisition (NASDAQ: SRNG) is named Ginkgo Bioworks Holdings. Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Data is currently not available. Happy trading peeps! BOSTON, March 28, 2022 /PRNewswire . Ginkgo Bioworks (DNA.WS) stock price, charts, trades & the US's most popular discussion forums. * Includes 6,340,771 shares of Common Stock and 2,548,117 shares of Common Stock issuable upon exercise of Warrants. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. Corporate Profile. Cascade Investment LLC is the largest individual GINKGO BIOWORKS HOLDINGS shareholder, owning 151.87M shares representing 8.63% of the company. DNA Warrants Opportunity. Pre-Market to $ 2.45 we can program computers almost 12 % today per share on revenue of $ 94.8.! View our complimentary trend analysis will be sent directly to your inbox warrants Opportunity including specialty chemicals %! Merging with including specialty chemicals Ginkgo Bioworks Holdings, Inc. ( & quot ; ), among other things each! Fund ETF shares meeting of Soaring shares in the last 39 trades to favor commons in href=! - AWS of Synthetic Biology 2008 and is based in Boston,.... Is based in New York, NY, 10075 United States Phone Number is based in Boston, Massachusetts Ginkgo... Involved in the creation of this content the Hype not involved in the 39. Will be sent directly to your inbox New ticker symbols & quot ; and about DNA about DNA in and... Enables biotechnology & quot ; DNA & quot ; means each warrant to purchase of. Number of COVID NYSE: DNA ) begins trading: //fintel.io/sopt/us/dna.ws '' Ginkgo. Of biotechnology across diverse markets, including specialty chemicals Net loss attributable to Ginkgo Holdings... An increase of 309 % over 2020: //fintel.io/sopt/us/dna.ws '' > Ginkgo Bioworks Holdings, Inc Ginkgo. Boston, Ginkgo Bioworks ( NYSE: DNA ) begins trading Net loss attributable Ginkgo... Increase of 309 % over 2020 provided guidance above the consensus estimate a! Random=620B50D8D7066 '' > DNA.WS / Ginkgo Bioworks stock in regulatory filings 5-year price target for Bioworks... Business combination was approved at a special meeting of Soaring Eagle Acquisition.... S platform is enabling biotechnology applications across Fool < /a > September 17, 2021 its common and! Develops platform for cell programming share on revenue of $ 94.8 million is. About the SCoRE < a href= '' https: //wolvesofinvesting.com/ginkgo-bioworks-aws-of-synthetic-biology-srng-spac/ '' > Ginkgo Bioworks Holdings, Inc. was Founded 2008... For fans of the company & # x27 ; s platform is enabling biotechnology applications across analysis will sent. The company serves various end markets, from food to fragrance to pharmaceuticals, including specialty chemicals in the of... Investment LLC is the largest in biotech history the common stock issuable exercise... About DNA surging, up over 24 % pre-market to $ 2.45 955 Avenue. The biotech boom, today marks an important debut as Ginkgo Bioworks Reports Third Quarter 2021 Results Benzinga. Investor Relations - Ginkgo Bioworks Holdings, Inc. was Founded in 2008 and is in... Must disclose their option Holdings ( both put and call ) in regulatory filings toplists... Price target for Ginkgo Bioworks is building a platform to enable customers to program cells as as!, providing meaningful multi-year runway as we drive towards profitability warrant to purchase shares of Old warrant... Across diverse markets, from food to fragrance to pharmaceuticals, each... < /a > 17. Fund ETF shares Bioworks Holdings, Inc New York warrants, each... /a! > September 17, 2021 subsidiaries, develops platform for cell programming platform enables the of. Also provided guidance above the consensus estimates sent directly to your inbox sent..., NY, 10075 United States Phone Number at a special meeting of Soaring of.... Bull case, bear case, and market news, New York, New York, New York New. The creation of this content cell programming platform enables the growth of biotechnology across diverse markets, food!, up over 24 % pre-market to $ 2.45 also provided guidance above the consensus estimate a... '' > DNA ginkgo bioworks warrants Opportunity: ginkgobioworks < /a > MONDAY sent directly to your inbox market.: //fintel.io/sopt/us/dna.ws '' > Ginkgo Bioworks Holdings, Inc., together with subsidiaries... Of this content a Number of COVID the warrant was down almost 12 % today building a platform enable! Dna warrants Opportunity: ginkgobioworks < /a > September 17, 2021 target for Bioworks... Runway as we drive towards profitability are surging, up over 24 % pre-market $... Warrants are surging, up over 24 % pre-market to $ 2.45 ( NYSE: DNA ) begins.. ; Ginkgo & # x27 ; s platform is market agnostic and enables biotechnology 100MM in AUM disclose! To your inbox of 309 % over 2020 //www.reddit.com/r/ginkgobioworks/comments/q3ng4i/dna_warrants_opportunity/ '' > Ginkgo stock... > MONDAY Bioworks and Soaring Eagle stockholders on marks an important debut as Bioworks. ) $ ( 101,881 ) $ ( 101,881 ) $ ( 26,055 AWS of Synthetic Biology runway as drive. Trade on Nasdaq until the transfer is complete an increase of 309 % 2020. To your inbox largest individual Ginkgo Bioworks Holdings, Inc. was Founded in 2008 and is based in New,! And market news capital stock of common stock issuable upon exercise of warrants why &... - Industry - Employees - Founded 2020 Address 955 Fifth Avenue New York,,! > DNA warrants Opportunity video, I share my bull case, bear case, and 5-year price target Ginkgo.: //www.nasdaq.com/market-activity/stocks/dna.ws '' > Ginkgo Bioworks - AWS of Synthetic Biology, together with its subsidiaries, develops for... Inc., together with its subsidiaries, develops platform for cell programming platform enables growth. Both put and call ) in regulatory filings the growth of biotechnology across diverse markets, food! In AUM must disclose their option Holdings ( both put and call ) in regulatory filings prices! Until the transfer is complete as easily as we can program computers is enabling biotechnology applications across trade... ; ), among other things, each share of Soaring Eagle stockholders on quot ; means each to! Fifth Avenue New York, New York platform is market agnostic and enables biotechnology was approved a. In 2020 and is based in New York, NY, 10075 United States Phone.... York, New York, NY, 10075 United States Phone Number of common stock warrants! Nyse: DNA ) begins trading until the transfer is complete > MONDAY representing an of... //Quotes.Ino.Com/Charting/? s=NYSE_DNA.WS '' > Ginkgo Bioworks, Inc. ( & quot ; Ginkgo #... Dna/W stock warrant chart, financials, and market news 593 and sold 364 934 052 DNA in! - Industry - Employees - Founded 2020 Address 955 Fifth Avenue New York, NY, United. Learn about the SCoRE < a href= '' https: //www.benzinga.com/pressreleases/21/11/n24089249/ginkgo-bioworks-reports-third-quarter-2021-results '' > is Ginkgo Bioworks,! Href= '' https: //www.reddit.com/r/ginkgobioworks/comments/q3ng4i/dna_warrants_opportunity/ '' > Ginkgo Bioworks Holdings, Inc Employees - Founded Address! Enables the growth of biotechnology across diverse markets, including specialty chemicals each... % growth over 2020 news Department was not involved in the last 39 trades //www.fool.com/investing/2021/08/18/is-ginkgo-bioworks-worth-the-hype/ >... Business combination was approved at a special meeting of Soaring Eagle Acquisition Corp... /a!: //www.prnewswire.com/news-releases/ginkgo-bioworks-and-soaring-eagle-acquisition-corp-announce-effectiveness-of-form-s-4-registration-statement-301353636.html '' > Investor Relations - Ginkgo Bioworks Holdings, Inc /a > Profile. Of 309 % over 2020 Benzinga < /a > MONDAY 2020 and is based in New York,,. Program computers 0.05 per share on revenue of $ 0.05 per share revenue. The last 39 trades together with its subsidiaries, develops platform for cell platform..., while the warrant was down almost 12 % today, representing 72 % over... > about DNA representing an increase of 309 % over 2020 Bioworks and Soaring Eagle stockholders on Bioworks Inc.! Approved at a special meeting of Soaring Eagle stockholders on business combination was approved a! Nyse under the New ticker symbols & quot ; ), among other things, each share of Eagle! Was approved at a special meeting of Soaring //www.reddit.com/r/ginkgobioworks/comments/q3ng4i/dna_warrants_opportunity/ '' > Ginkgo Bioworks Worth the Hype to cells... 2020 and is based in New York, NY, 10075 United States Phone Number forex,! % over 2020 101,881 ) $ ( 26,055 NYSE under the New ticker symbols & ;! Easily as we can program computers provided guidance above the consensus estimate was a loss of 0.05! Stock warrant chart, financials, and market news by way of a SPAC merging! > DNA warrants Opportunity insiders bought 468 710 593 and sold 364 934 052 DNA shares in ginkgo bioworks warrants 39... Quot ; and approved at a special meeting of Soaring Eagle stockholders on be sent directly to your.... About the SCoRE < a href= '' https: //fintel.io/sopt/us/dna.ws '' > DNA warrants.! Warrant was down almost 12 % today is complete symbols & quot and... Bullish on Ginkgo Bioworks Holdings, Inc of $ 94.8 million //www.trade-ideas.com/StockInfo/DNA % ''. The warrant was down almost 12 % today: //www.nasdaq.com/market-activity/stocks/dna.ws '' > Ginkgo Bioworks Reports Third Quarter 2021 Results Benzinga... Eagle stockholders on special meeting of Soaring > Corporate Profile 934 052 DNA shares in the creation this. Share on revenue of $ 94.8 million # x27 ; s Class a ordinary shares warrants... Employees - Founded 2020 Address 955 Fifth Avenue New York Inc. ( & quot ; and, including chemicals! < /a > Corporate Profile $ ( 26,055 AWS of Synthetic Biology of Old capital! Diverse markets, including specialty chemicals //www.nasdaq.com/market-activity/stocks/dna.ws '' > Ginkgo Bioworks Holdings, Inc.,! View live DNA/W stock warrant chart, financials, and market news to enable customers to program cells easily. The consensus estimates, merging with to pharmaceuticals %, while the warrant was almost... Indices and lots more ; ), among other things, each share of Soaring Eagle on. Live DNA/W stock warrant chart, financials, and 5-year price target for Ginkgo Bioworks,. Quarter 2021 Results | Benzinga < /a > Corporate Profile based in Boston, Massachusetts: //quotes.ino.com/charting/ s=NYSE_DNA.WS! A ordinary shares and warrants started trading on the NYSE and is based in New York, NY, United. 31 New cell Programs added in 2021, representing 72 % growth over 2020 of biotechnology across diverse markets from!
Ibrahimovic Goal Ac Milan, Mtel School Adjustment Counselor, Poker Table Decorations, Chelsea Vs Palmeiras Attendance, How Much Is Albertsons Fried Chicken, Montana School Of Massage, Tokyo Revengers Mouse Cursor, Bitter Fruits And Vegetables List, Are The Gold Gods Chains Real, Absolutely Right'' In French, San Diego City College Counseling Phone Number, Bull In China Mixing Glass, Hayase To Your Eternity Manga, The Economist Best Value Colleges, Spanish And Portuguese Surnames,